Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

Carleton University

$19,000.00

Treatment of pharmaceuticals and EDCs using a biofilter and membrane bioreactor (MBR)

FY 2009-10

Summary
In the past decade, pharmaceutically active compounds (PhACs), endocrine disrupting compounds (EDCs) and other synthetic organic compounds have been found in wastewater effluent, and in drinking water supplies. Due to their potential impact on aquatic life and human health a key topic of interest in research and society is the removal of these compounds from water. Membrane-bioreactor (MBR) systems with biofiltration may be one tool available to remove these compounds from water through microbial degradation. MBR systems combine conventional processes such as coagulation, aeration, activated sludge, and physical filtration into one unit, allowing for a compact design and potential improvements in produced water quality. However, the limitation to membrane implementation is fouling. Membrane fouling impedes on the production of treated water, increasing operational and maintenance costs. Membrane fouling is comprised of four main areas: organic fouling, biofouling, colloidal fouling, and scaling. Each type of fouling requires different strategies to minimize and control in order to prevent loss of water production. Therefore, it is important to understand what type of fouling occurs in a given MBR system. Currently, Canadian and US, PhAC/EDC research is mainly focused on removal at drinking water plants, although these compounds originate at the wastewater (sewage) plant. This research will assesss removal of these compounds at the wastewater plant. A wastewater MBR combined with a biofilter system may be more effective at treatment due to the diverse nature of microbes present in wastewater plants. The overall scientific approach will assess the removal of individual PhACs/EDCs in conjunction with the type and severity of fouling that occurs on the membranes in the MBR and biofilter system.
Program
Discovery Grants Program - Individual
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
298309-2009
Name nom
Basu, Onita
Department département
Civil and Environmental Engineering
Organization id
23
Institution établissement
Carleton University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2009
Competition year année de concours
2009
Award amount
19000
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1062
Committee name en
Civil Engineering - B
Committee name fr
Génie civil - B
Area of application code
702
Area of application group en
Transportation systems and services
Area of application group fr
Services et systèmes de transport
Area of application en
Water
Area of application fr
Maritime
Research subject code
1500
Research subject group en
Environmental engineering
Research subject group fr
Génie de l'environnement
Research subject en
Environmental engineering
Research subject fr
Génie de l'environnement
Partie
1
Nb partie
5
Application title
Treatment of pharmaceuticals and EDCs using a biofilter and membrane bioreactor (MBR)
Keyword
NA
Application summary
In the past decade, pharmaceutically active compounds (PhACs), endocrine disrupting compounds (EDCs) and other synthetic organic compounds have been found in wastewater effluent, and in drinking water supplies. Due to their potential impact on aquatic life and human health a key topic of interest in research and society is the removal of these compounds from water. Membrane-bioreactor (MBR) systems with biofiltration may be one tool available to remove these compounds from water through microbial degradation. MBR systems combine conventional processes such as coagulation, aeration, activated sludge, and physical filtration into one unit, allowing for a compact design and potential improvements in produced water quality. However, the limitation to membrane implementation is fouling. Membrane fouling impedes on the production of treated water, increasing operational and maintenance costs. Membrane fouling is comprised of four main areas: organic fouling, biofouling, colloidal fouling, and scaling. Each type of fouling requires different strategies to minimize and control in order to prevent loss of water production. Therefore, it is important to understand what type of fouling occurs in a given MBR system. Currently, Canadian and US, PhAC/EDC research is mainly focused on removal at drinking water plants, although these compounds originate at the wastewater (sewage) plant. This research will assesss removal of these compounds at the wastewater plant. A wastewater MBR combined with a biofilter system may be more effective at treatment due to the diverse nature of microbes present in wastewater plants. The overall scientific approach will assess the removal of individual PhACs/EDCs in conjunction with the type and severity of fouling that occurs on the membranes in the MBR and biofilter system.